Nasdaq Bear Market: 3 Remarkable Growth Stocks Down Over 90% That Can Double Your Money by 2025The Motley Fool • 11/22/22
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in AdultsPRNewsWire • 11/18/22
Nasdaq Bear Market: 3 Phenomenal Bargains That Can Double Your Money by 2027The Motley Fool • 11/10/22
Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for Use as a Booster in AdultsPRNewsWire • 11/09/22
Novavax stock rallies, even as company offers a dimmer sales forecast for vaccinesMarket Watch • 11/08/22
The Make-Or-Break Moment For Novavax: What To Watch In Third-Quarter EarningsInvestors Business Daily • 11/08/22
Novavax says Phase 3 trial of omicron-targeting COVID vaccine supports its use as a boosterMarket Watch • 11/08/22
Novavax Phase 3 COVID-19 Omicron Trial Supports the Continued and Future Use of Novavax Prototype Vaccine as a BoosterPRNewsWire • 11/08/22